StonvexLoading…
StonvexStonvexStonvexCore line items from CSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Q3 2023 2023-09-30 |
|---|---|---|---|---|---|
Revenue | $68.59M | $3.49M | $2.28M | $1.19M | $3.84M |
Operating Income | Not available | $17.62M | $11.27M | $4.08M | $85.96M |
Net Income | Not available | $-6.25M | $-5.20M | $-3.90M | $49.48M |
EPS (Diluted) | $-0.24 | $-0.96 | $-0.56 | $-0.37 | $2.96 |
Total Assets | Not available | $1.89B | $1.90B | $1.90B | $1.88B |
Total Liabilities | Not available | $982.27M | $984.57M | $979.83M | $901.36M |
Cash & Equivalents | Not available | $14.45M | $14.33M | $12.68M | $29.70M |
Free Cash Flow OCF − CapEx | Not available | $32.15M | $11.68M | $2.59M | $38.02M |
Shares Outstanding | Not available | 16.57M | 15.06M | 14.91M | 15.05M |